Killian S Hanlon

Killian S Hanlon

Harvard University

H-index: 11

North America-United States

About Killian S Hanlon

Killian S Hanlon, With an exceptional h-index of 11 and a recent h-index of 11 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Gene therapy, AAV, vector engineering.

His recent articles reflect a diverse array of research interests and contributions to the field:

In vivo selection in non-human primates identifies superior AAV capsids for on-target CSF delivery to spinal cord

Rescue of hearing by adenine base editing in a humanized mouse model of Usher syndrome type 1F

An engineered adeno-associated virus capsid mediates efficient transduction of pericytes and smooth muscle cells of the brain vasculature

Genomic investigations of unexplained acute hepatitis in children

Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial Dysfunction

Engineered adeno-associated (aav) vectors for transgene expression

Recombinant adeno associated virus encoding clarin-1 and uses thereof

The AAV9 variant capsid AAV-F mediates widespread transgene expression in nonhuman primate spinal cord after intrathecal administration

Killian S Hanlon Information

University

Position

Harvard Medical School

Citations(all)

755

Citations(since 2020)

750

Cited By

206

hIndex(all)

11

hIndex(since 2020)

11

i10Index(all)

11

i10Index(since 2020)

11

Email

University Profile Page

Google Scholar

Killian S Hanlon Skills & Research Interests

Gene therapy

AAV

vector engineering

Top articles of Killian S Hanlon

In vivo selection in non-human primates identifies superior AAV capsids for on-target CSF delivery to spinal cord

bioRxiv

2023/9/13

Rescue of hearing by adenine base editing in a humanized mouse model of Usher syndrome type 1F

Molecular Therapy

2023/8/2

Killian S Hanlon
Killian S Hanlon

H-Index: 6

Eric Zinn
Eric Zinn

H-Index: 5

An engineered adeno-associated virus capsid mediates efficient transduction of pericytes and smooth muscle cells of the brain vasculature

Human Gene Therapy

2023/8/1

Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial Dysfunction

Pharmaceutics

2023/1/18

Engineered adeno-associated (aav) vectors for transgene expression

2022/6/23

Recombinant adeno associated virus encoding clarin-1 and uses thereof

2022/4/21

The AAV9 variant capsid AAV-F mediates widespread transgene expression in nonhuman primate spinal cord after intrathecal administration

Human Gene Therapy

2022/1/1

Yi Gong
Yi Gong

H-Index: 7

Killian S Hanlon
Killian S Hanlon

H-Index: 6

Ming Cheng
Ming Cheng

H-Index: 2

AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear

Molecular Therapy Methods & Clinical Development

2021/6/11

Killian S Hanlon
Killian S Hanlon

H-Index: 6

Delivering AAV to the central nervous and sensory systems

2021/6/1

Killian S Hanlon
Killian S Hanlon

H-Index: 6

Retinal Promoter and Uses Thereof

2021/2/25

Novel 199 base pair NEFH promoter drives expression in retinal ganglion cells

Scientific Reports

2020/10/5

In vivo engineering of lymphocytes after systemic exosome-associated AAV delivery

Scientific Reports

2020/3/11

Killian S Hanlon
Killian S Hanlon

H-Index: 6

Preclinical testing of AAV9-PHP. B for transgene expression in the non-human primate cochlea

Hearing research

2020/9/1

Killian S Hanlon
Killian S Hanlon

H-Index: 6

Versatile Role Of Rab27a In Glioma: Effects On Release Of Extracellular Vesicles, Cell Viability And Tumor Progression

Frontiers in Molecular Biosciences

2020/11/12

Killian S Hanlon
Killian S Hanlon

H-Index: 6

See List of Professors in Killian S Hanlon University(Harvard University)